Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
13.82
-0.11 (-0.79%)
Jan 14, 2025, 4:00 PM EST - Market closed
Arcus Biosciences Employees
Arcus Biosciences had 577 employees as of December 31, 2023. The number of employees increased by 77 or 15.40% compared to the previous year.
Employees
577
Change (1Y)
77
Growth (1Y)
15.40%
Revenue / Employee
$455,806
Profits / Employee
-$467,938
Market Cap
1.26B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RCUS News
- 5 hours ago - Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 - Seeking Alpha
- 1 day ago - Arcus: Excellent Pipeline And Collaborations, Cash Runway - Seeking Alpha
- 21 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 26 days ago - Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 2 months ago - Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update - Business Wire
- 2 months ago - Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer - Business Wire